Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem is expected to experience continued growth in their Human Nutrition and Health segment, along with a strong balance sheet and low leverage ratio. Risks to their outlook include slower growth in their base businesses, inflationary pressures, and potential disruptions to their European business. However, the company's expansion into new nutrition products and potential partnerships could mitigate these risks. Financial metrics, such as net interest expense and cash flows, remain strong and the company's stock may be undervalued based on a comparable universe-derived forward P/E multiple of 36.8x. Revenue and earnings for fourth quarter 2025 and full-year 2025 were in line with expectations, and forecasts for full-year 2026 and 2027 suggest continued growth and improvements in margins. The recent imposition of anti-dumping duties in Europe for one of Balchem's key products is expected to positively impact sales in that region. The company's effective tax rate is anticipated to increase slightly in the coming years, but Balchem's strong financial position and potential for M&A activity suggest potential for future share repurchases or debt repayment.

Bears say

Balchem is projected to have steady top-line growth and fairly consistent earnings over the next few years, but the recent modest revenue miss and potential impact from geopolitical tensions may hinder its performance. Additionally, while the HNH segment remains strong, there have also been some misses in the animal health and nutrition and specialty product segments. The company's gross margin has also seen a slight decrease due to higher manufacturing input costs. Overall, the company may face challenges in the near future that could affect its bottom line.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.